What is STERIS's D&A?

STERIS (STE) reported D&A of $123.4M in Q1 2026.

How has STERIS's D&A changed year-over-year?

STERIS's D&A increased by 0.9% year-over-year, from $122.3M to $123.4M.

What is the long-term trend for STERIS's D&A?

Over 4 years (2022 to 2026), STERIS's D&A has grown at a -3.2% compound annual growth rate (CAGR), from $553.1M to $486.5M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

STERIS STE D&A

D&A at other companies

Baxter InternationalBAX

$237M-4.0%

3MMMM

$326M+12.4%

CONMEDCNMD

$8.7M0.0%

Charles River LaboratoriesCRL

$67.15M-44.2%

Tenet HealthcareTHC

$229M+11.2%

GE HealthCare TechnologiesGEHC

——

Segments

By segment

See full

AST$41.6M+14.0%

Other financials

Income statement

See full

Revenue$1.6B+7.3%

Gross profit$697.2M+8.8%

Operating income$316.8M+46.6%

Net income$220.2M+51.2%

EPS (diluted)$2.24+52.4%

Balance sheet

See full

Cash & equivalents$439.6M+156%

Total debt$2.1B-10.3%

Total equity$7.2B+8.8%

Total assets$10.7B+5.8%

Cash flow

See full

Operating cash flow$335.4M+28.6%

CapEx$90.2M+27.2%

Free cash flow$245.2M+29.1%

Valuation

See full

Market cap$20.52B-9.4%

Enterprise value$22.17B-8.8%

P/E26.2×-8.8×

P/S3.5×-0.6×

Profitability

See full

Gross margin44.2%+0.2pp

Operating margin18.6%+2.7pp

Net margin13.2%+1.9pp

FCF margin16.4%+2.1pp

Returns & leverage

See full

Return on equity11.3%+1.8pp

Debt / equity0.3×-0.1×

Current ratio2.1×+0.1×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is STERIS's D&A?: STERIS (STE) reported D&A of $123.4M in Q1 2026.
How has STERIS's D&A changed year-over-year?: STERIS's D&A increased by 0.9% year-over-year, from $122.3M to $123.4M.
What is the long-term trend for STERIS's D&A?: Over 4 years (2022 to 2026), STERIS's D&A has grown at a -3.2% compound annual growth rate (CAGR), from $553.1M to $486.5M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.